Clermont-Ferrand, France

Elisabeth Miot-Noirault

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.2

ph-index = 1


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Elisabeth Miot-Noirault: A Pioneer in PET Imaging Technologies

Introduction

Elisabeth Miot-Noirault is a notable inventor based in Clermont-Ferrand, France, known for her significant contributions to the fields of chemistry and medical imaging. With a total of two patents to her name, she has made strides in enhancing diagnostic techniques through innovative compounds.

Latest Patents

One of her latest patents focuses on "Macrocyclic complexes, their process of preparation and use as PET imaging agents." This invention pertains to compounds of formula (I) and includes their preparation methods and compositions. These compounds serve as diagnostic agents in PET imaging, showcasing her focus on improving medical diagnostics.

Another significant patent is for "Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors." This invention describes the compound of formula (I) as well. It also addresses pharmaceutical compositions that include these compounds and their applications in diagnosis, specifically with SPECT or PET imaging, as well as targeted radionuclide therapy for melanoma.

Career Highlights

Elisabeth has worked with several reputable institutions during her career. She has been associated with Inserm (Institut National De La Santé Et De Le Recherche Médicale) and Université D'Auvergne Clermont 1, contributing to research and development in the field of medical science.

Collaborations

In her efforts to innovate, Elisabeth has collaborated with esteemed colleagues such as Jean-Claude Madelmont and Jean-Michel Chezal. These partnerships have played a vital role in advancing her research projects and patent applications.

Conclusion

Elisabeth Miot-Noirault stands out as a pioneering inventor whose work in medical imaging technologies has the potential to impact diagnostic practices significantly. Her patents reflect a commitment to improving health outcomes and showcase the power of innovation in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…